News

Teitur is happy to have secured funding from the Innobooster grant from Innovation Fund Denmark. The grant will allow the company to finalize studies to nominate a candidate for IND…

Teitur today announces the successful closing of a €400.000 convertible loan from Sunstone to advance the preclinical program targeting neurodegenerative diseases.

Teitur is happy to have secured funding from the Innobooster grant from Innovation Fund Denmark. The grant will enable the company to advance the innovative peptide project for treating patients…

The pharma company Teitur Trophics that targets neurodegenerative diseases has joined the BII Creation House program. As part of the Creation House program, Teitur Trophics will have access to a…